4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ·Healthcare·Biotechnology
$12.21
-0.33%
Mkt Cap $676.74M
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (19 analysts)
$29.67
Range $20.00 – $37.00
Implied Upside
+143.0%
Consensus $29.67 vs current $12.21